1.
Ganzel C, Kharit M, Duksin C, Rowe JM. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia. Haematologica 2018; 103(10):e489-e490; https://doi.org/10.3324/haematol.2018.197640.